Literature DB >> 7251510

A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. III. Isolation and identification of an early aromatic ansamycin-precursor containing the seven-carbon amino starter-unit and three initial acetate/propionate-units of the ansa chain.

O Ghisalba, H Fuhrer, W J Richter, S Moss.   

Abstract

A number of rifamycin non-producing UV-mutants derived from Nocardia mediterranei strains N813 (rifamycin B producer) and A10 (aro--mutant excreting shikimate derived from strain N813) were found to accumulate an identical complex of aromatic components instead of rifamycin B. The main component of this aromatic complex, product P8/1-OG, was isolated from six of these P--mutant strains and identified spectroscopically as a very early precursor in the biosynthesis of rifamycins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251510     DOI: 10.7164/antibiotics.34.58

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesis.

Authors:  Ingo V Hartung; Mathew A Rude; Nathan A Schnarr; Daniel Hunziker; Chaitan Khosla
Journal:  J Am Chem Soc       Date:  2005-08-17       Impact factor: 15.419

2.  Direct evidence that the rifamycin polyketide synthase assembles polyketide chains processively.

Authors:  T W Yu; Y Shen; Y Doi-Katayama; L Tang; C Park; B S Moore; C Richard Hutchinson; H G Floss
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli.

Authors:  Kenji Watanabe; Mathew A Rude; Christopher T Walsh; Chaitan Khosla
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-29       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.